Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CASI Pharmaceuticals (DE:ENM)
STUTTGART:ENM
RESEARCH TOOLSreports
Holding DE:ENM?
Track your performance easily
ENM Stock Chart & Stats
Day’s Range€1.53 - €1.54
52-Week Range― - ―
Previous Close€1.54
Volume0.00
Average Volume (3M)N/A
Market Cap
$31.38M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding123,943,829
10 Day Avg. Volume0
30 Day Avg. Volume0
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.33
Price to Sales (P/S)10.16
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-3.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€9.14Price Target Upside493.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
CASI Pharmaceuticals News
ENM FAQ
What was CASI Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is CASI Pharmaceuticals’s market cap?
Currently, no data Available
When is CASI Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CASI Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is CASI Pharmaceuticals overvalued?
According to Wall Street analysts CASI Pharmaceuticals’s price is currently Undervalued.
Does CASI Pharmaceuticals pay dividends?
CASI Pharmaceuticals does not currently pay dividends.
What is CASI Pharmaceuticals’s EPS estimate?
CASI Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CASI Pharmaceuticals have?
Currently, no data Available
What happened to CASI Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CASI Pharmaceuticals?
Among the largest hedge funds holding CASI Pharmaceuticals’s share is Consonance Capital. It holds CASI Pharmaceuticals’s shares valued at N/A.
---
CASI Pharmaceuticals Stock Smart Score
Company Description
CASI Pharmaceuticals
CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. Its products include ZEVALIN, EVOMELA and MARQIBO. CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
---
ENM Stock 12 Month Forecast
Average Price Target
€9.14
▲(493.34% Upside)
Technical Analysis
Cellectar Biosciences
―
Ardelyx
―
Aurinia Pharmaceuticals
―
CASI Pharmaceuticals
―
Bellicum Pharmaceuticals
―
---